Structural and conformational aspects of the binding of aryl-alkyl amines to the phencyclidine binding site.
Thurkauf
A
A
Laboratory of Medicinal Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
Monn
J
J
Mattson
M V
MV
Jacobson
A E
AE
Rice
K C
KC
D000818:Animals; D000927:Anticonvulsants; D001921:Brain / Q000187:drug effects*; D055598:Chemical Phenomena; D002621:Chemistry; D003986:Dibenzocycloheptenes / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D016291:Dizocilpine Maleate; D006801:Humans; D008968:Molecular Conformation; D010622:Phencyclidine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D010623:Phencyclidine Abuse / Q000209:etiology*; D017981:Receptors, Neurotransmitter / Q000187:drug effects*; D017478:Receptors, Phencyclidine; D013329:Structure-Activity Relationship
D000927:Anticonvulsants; D003986:Dibenzocycloheptenes; D017981:Receptors, Neurotransmitter; D017478:Receptors, Phencyclidine; D016291:Dizocilpine Maleate; D010622:Phencyclidine